References
- World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. 2009. Available at: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf [Last accessed 3 September 2014]
- Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23
- Chow CK, Teo KK, Rangarajan S, et al.; PURE (Prospective Urban Rural Epidemiology) Study Investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013;310:959-68
- Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;31:1281-357
- Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010;55:399-407
- van den Meiracker AH. A global approach to hypertension. EuroIntervention 2013;9(Suppl R):R16-20
- Hair PI, Scott LJ, Perry CM. Fixed-dose combination lercanidipine/enalapril. Drugs 2007;67:95-106
- Arnaout S; DUAL Investigators Study Group. Efficacy and safety of lercanidipine/enalapril fixed combination in Lebanon: a prospective observational study. Curr Med Res Opin 2015;31:187-90
- Maldonado J, Pereira T, Tavares A. Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in Portugal. Drugs R D 2014;14:147-54
- Scholze J, Bramlage P, Trenkwalder P, Kreutz R. Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure. Expert Opin Pharmacother 2011;12:2771-9
- Mancia G, Coca A, Chazova I, et al.; FELT investigators. Effects on office and home blood pressure of the lercanidipine–enalapril combination in patients with stage 2 hypertension: a European randomized, controlled clinical trial. J Hypertens 2014;32:1700-7
- Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 2010;1:97-111
- Mancia G, Parodi A, Merlino L, Corrao G. Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class. J Hypertens 2011;29:1012-18
- Corrao G, Nicotra F, Parodi A, et al. Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice. Hypertension 2011;58:566-72
- Pallarés-Carratalá V, Pascual Pérez R. Non-compliance and therapeutic inertia: two unanswered questions in clinical practice. Curr Med Res Opin 2014;30:839-40
- Armario P, Waeber B. Therapeutic strategies to improve control of hypertension. J Hypertens 2013;31(Suppl 1):S9-S12